(143 days)
Not Found
No
The summary describes a mechanical embolic protection device and does not mention any AI or ML components or functionalities.
Yes.
The device is used to contain and remove embolic material during angioplasty and stenting procedures, which directly treats a medical condition.
No
The device is described as an "embolic protection system to contain and remove embolic material." Its function is therapeutic (to prevent embolism during procedures), not diagnostic.
No
The device description clearly outlines physical components like a Capture Wire, nitinol mesh filter, stainless steel wire, and a dual-ended catheter, indicating it is a hardware-based medical device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The SpideRX Embolic Protection Device is a physical device used during a medical procedure (angioplasty and stenting) to capture and remove embolic material from the carotid arteries. It does not analyze samples taken from the body.
- Intended Use: The intended use clearly describes a procedural intervention, not a diagnostic test.
Therefore, the SpideRX Embolic Protection Device falls under the category of a medical device used for treatment/intervention, not an in vitro diagnostic.
N/A
Intended Use / Indications for Use
The SpideRX Embolic Protection Device is indicated for use as a guidewire and embolic protection system to contain and remove embolic material (thrombus/debris) while performing angioplasty and stenting procedures in carotid arteries. The diameter of the artery at the site of filter basket placement should be between 3.0mm and 7.0mm.
Product codes
NTE
Device Description
The SpideRX Embolic Protection Device is a percutaneously delivered distal embolic protection system that can be delivered over any 0.014" or 0.018" guidewire. The SpideRX Embolic Protection Device contains a Capture Wire composed of a nitinol mesh filter mounted on a convertible 190/320 cm PTFEcoated 0.014" stainless steel wire, and a dual-ended SpideRX Catheter for delivery and recovery.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Carotid arteries
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-Clinical: In vitro testing of the SpideRX Embolic Protection Device consisted of biocompatibility, sterilization, packaging, product shelf life and consisted of crossing Functional performance testing was also completed in portormalies testings verified that the SpideRX Device is adequate for its intended use. Additionally, the test results demonstrated that the SpideRX Device is equivalent to its predicate devices.
Clinical: The SpideRX Arm of the Carotid Revascularization with ev3 Arterial Technology Evolution (CREATE) Trial was a non-randomized multi-center registry study that was performed to assess the safety and performance of the SpideRX Device when used with the commercially available ACCULINK™ Carotid Stent System. The differences observed between the primary endpoint event rates were not statistically significant, which demonstrate the safety and performance of the SpideRX Device for its intended use.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.1250 Percutaneous catheter.
(a)
Identification. A percutaneous catheter is a device that is introduced into a vein or artery through the skin using a dilator and a sheath (introducer) or guide wire.(b)
Classification. Class II (performance standards).
0
510(k) Summary SpideRX™ Embolic Protection Device
510(k) Number: K052659
This 510(k) summary is being submitted in accordance with the requirements of 2 i CFR 8807.92.
Submitter/Contact Person:
| Submitter's Name: | ev3 Inc.
4600 Nathan Lane North
Plymouth, MN 55442
Tel: (763) 398-7000
Fax: (763) 398-7200 |
|-------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Official Contact: | Glen Smythe
Sr. Regulatory Affairs Specialist
ev3 Inc.
4600 Nathan Lane North
Plymouth, MN 55442
Tel: (763) 398-7391
Fax: (763) 398-7200
gsmythe@ev3.net |
Summary Preparation Date:
September 22, 2005
Device Name and Classification:
| Trade Name: | SpideRX TM Embolic Protection Device |
|---|---|
| Common Name/Usual Name: | Embolic Protection Device |
| Classification Name: | Catheter, Percutaneous |
| Class: | Class II, 21 CFR 870.1250 |
Predicate Devices:
RX ACCUNET™ Embolic Protection System (K042218) FilterWire EZTM Embolic Protection System (K032884)
Device Description:
The SpideRX Embolic Protection Device is a percutaneously delivered distal embolic protection system that can be delivered over any 0.014" or 0.018" guidewire. The SpideRX Embolic Protection Device contains a Capture Wire composed of a nitinol mesh filter mounted on a convertible 190/320 cm PTFEcoated 0.014" stainless steel wire, and a dual-ended SpideRX Catheter for delivery and recovery.
1
Intended Use:
The SpideRX Embolic Protection Device is indicated for use as a guidewire and embolic protection system to contain and remove embolic material (thrombus/debris) while performing angioplasty and stenting procedures in (inrotious areries. The diameter of the artery at the site of filter basket placement should be between 3.0mm and 7.0mm.
Summary of Technological Characteristics:
The SpideRX Embolic Protection Device is a rapid exchange distal embolic r no Spideret Line on is compatible with 0.014"/0.018" primary guidewires and utilizes a nitinol mesh filter to capture debris.
The delivery end of the SpideRX dual-ended Catheter is placed distal to the lesion by tracking over the primary guidewire. The primary guidewire is then removed and the SpideRX Capture Wire is advanced through the delivery end of the SpideRX Catheter. Filter deployment is accomplished by holding the SpideRX Capture Wire steady while pulling back and removing the SpideRX Catheter. When deployed, the nitinol mesh filter opens, apposes the vessel wall, and then acts as a strainer by capturing debris while allowing uninterrupted blood flow distally. The Capture Wire then functions as the guidewire while percutaneous transluminal angioplasty or stenting procedures are performed. Upon completion of the intervention, the recovery end of the SpideRX Catheter is advanced over the Capture Wire and the filter is recovered into the SpideRX Catheter, closing the filter and trapping the embolic debris inside the filter. The system is then removed.
The SpideRX Embolic Protection Device is substantially equivalent to the Guidant® RX ACCUNET™ Embolic Protection System (K042218) and the Boston Scientific FilterWire EZ Embolic Protection System (K032884) in regards to device design, principals of operation and materials. The SpideRX Embolic Protection Device is also substantially equivalent to the RX ACCUNET in intended use. The following features are the same or similar between the SpideRX Device and the predicate devices:
- Distal filter embolic protection .
- Ranid-exchange devices .
- Filter/basket component .
- Compatible with 0.014" interventional devices .
- Capture Wire accommodates both rapid exchange and over-the-wire PTA . devices (FilterWire EZ and RX ACCUNET are available in both 190 and 300cm lengths, while SpideRX Device wire is 320cm in length, and snaps to 190cm to accommodate rapid exchange devices)
- Intended for use in similar vessel sizes .
- Radionaque guidewire tips and filter markers .
- Radiopaque markers on sheath/catheter tips .
052659
2
Comparisons of the SpideRX Device to the predicate devices show that technological characteristics such as materials, biocompatibility, performance technological onaracteries ackaging are substantially equivalent to the currently marketed RX ACCUNET and FilterWire EZ devices.
Summary of Testing:
Non-Clinical: In vitro testing of the SpideRX Embolic Protection Device consisted of biocompatibility, sterilization, packaging, product shelf life and consisted of crossing Functional performance testing was also completed in portormalies testings verified that the SpideRX Device is adequate for its intended use. Additionally, the test results demonstrated that the SpideRX Device is equivalent to its predicate devices.
Clinical: The SpideRX Arm of the Carotid Revascularization with ev3 Arterial Technology Evolution (CREATE) Trial was a non-randomized multi-center registry study that was performed to assess the safety and performance of the SpideRX Device when used with the commercially available ACCULINK™ Carotid Stent System. The differences observed between the primary endpoint event rates were not statistically significant, which demonstrate the safety and performance of the SpideRX Device for its intended use.
Statement of Equivalence:
The SpideRX Embolic Protection Device is substantially equivalent to the currently marketed RX ACCUNET™ Embolic Protection System (K042218) in intended use, materials, technological characteristics and performance. The SpideRX Embolic Protection Device is substantially equivalent to the FilterWire EZTM Embolic Protection System (K032884) in materials, technological characteristics and performance.
3
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
FEB 1 7 2006
ev3 Endovascular Inc. c/o Mr. Glen D. Smythe Senior Regulatory Affairs Specialist 4600 Nathan Lane North Plymouth, MN 55442-2920
Re: K052659
SpideRXTM Embolic Protection Device Regulation Number: 21 CFR 870.1250 Regulation Name: Percutaneous Catheter Regulatory Class: Class II Product Code: NTE Dated: February 10, 2006 Received: February 13, 2006
Dear Mr. Smythe:
We have reviewed your Section 510(k) premarket notification of intent to market the device wt nave reviewed your becamed the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate for use stated in the encreated ) 76, the enactment date of the Medical Device Amendments, or to commerce prior to May 20, 2017, 11:12 accordance with the provisions of the Federal Food, Drug, de necs mat have been recar require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
4
Please be advised that FDA's issuance of a substantial equivalence determination does not mean Please be advised that IDA's issualled of a susplies with other requirements of the Act that TDA has made a determination and Joint Federal agencies. You must of any Federal Statures and regulations administers of the registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set CFK Fart 807), ademig (21 OFR Part 820); and If applicable, the electronic forth in the quality systems (QD) regulanen (Sections 531-542 of the Act); 21 CFR 1000-1050. product radiation control provisions (Declosis over device as described in your Section 510(k) I his letter will anow you to begin maneting your antial equivalence of your device to a legally premarket nothcation. The PDA maing of basification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please If you ucare specific advice 101-300-2401 276-0120. Also, please note the regulation entitled, contact the Office of Complance as (21 notification" (21CFR Part 807.97). You may obtain Milsolanding of Icrerchee to premantonibilities under the Act from the Division of Small other general international and Consumer Assistance at its toll-free number (800) 638-2041 or Manufacturers, International and Consultip://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Bhimmar for
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
Indications For Use
510(k) Number (if known): ___________________________________________________________________________________________________________________________________________________
Device Name: SpideRX™ Embolic Protection Device
Indications for Use:
The SpideRX Embolic Protection Device is indicated for use as a guidewire and embolic protection system to contain and remove embolic material (thrombus/debris) while performing angioplasty and stenting procedures in carotid arteries. The diameter of the artery at the site of filter basket placement should be between 3.0mm and 7.0mm.
Over-The-Counter Use Prescription Use × AND/OR (21 CFR 801 Subpart C) (Part 21 CFR 801 Subpart D) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Bhumima
Non Sign On
antion of Cardlove scular Devices . Jik) Number
Page 1 of 1